EUVIMEDObjevte EUVIMED
Crossref

High salt induces cognitive impairment via the interaction of the angiotensin II‐AT 1 and prostaglandin E2‐EP 1 systems

Hisayoshi Kubota, Kazuo Kunisawa, Bolati Wulaer iD, Masaya Hasegawa, Hitomi Kurahashi, Takatoshi Sakata, Hiroyuki Tezuka, Masanori Kugita, Shizuko Nagao, Taku Nagai, Tomoyuki Furuyashiki iD, Shuh Narumiya and 3 more

British Journal of Pharmacology · 2023

DOI: 10.1111/bph.16093 ↗

At a glance

Journal article in British Journal of Pharmacology, 2023. Written by Hisayoshi Kubota and 14 co-authors. Institution: Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Scienc…. Major MEDLINE topics: Hypertension, Cognitive Dysfunction. Cited 18 times so far (Crossref); 71 references. Funded by: Japan Society for the Promotion of Science, Japan Science and Technology Agency, Smoking Research Foundation.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Purpose High salt (HS) intake has been associated with hypertension and cognitive impairment. It is well known that the angiotensin II (Ang II)‐AT 1 receptor and prostaglandin E2 (PGE2)‐EP 1 receptor systems are involved in hypertension and neurotoxicity. However, the involvement of these systems in HS‐mediated hypertension and emotional and cognitive impairments remains unclear. Experimental Approach Mice were loaded with HS solution (2% NaCl drinking water) for 12 weeks, and blood pressure was monitored. Subsequently, effects of HS intake on emotional and cognitive function and tau phosphorylation in the prefrontal cortex (PFC) and hippocampus (HIP) were investigated. The involvement of Ang II‐AT 1 and PGE2‐EP 1 systems in HS‐induced hypertension and neuronal and behavioural impairments was examined by treatment with losartan, an AT 1 receptor blocker (ARB), or EP 1 gene knockout. Key Results We demonstrate that hypertension and impaired social behaviour and object recognition memory following HS intake may be associated with tau hyperphosphorylation, decreased phosphorylation of Ca 2+ /calmodulin‐dependent protein kinase II (CaMKII), and postsynaptic density protein 95 (PSD95) expression in the PFC and HIP of mice. These changes were blocked by pharmacological treatment with losartan or EP 1 receptor gene knockout. Conclusions and Implications Our findings suggest that the interaction of Ang II‐AT 1 receptor and PGE2‐EP 1 receptor systems could be novel therapeutic targets for hypertension‐induced cognitive impairment.

Subjects

MeSH terms (MEDLINE)

HypertensionCognitive DysfunctionMiceAnimalsLosartanSodium ChlorideDinoprostoneAngiotensin IIAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsSodium Chloride, DietaryReceptor, Angiotensin, Type 1

Author keywords

angiotensin IIcognitive impairmenthypertensionprostaglandin E2tau hyperphosphorylation

Substances

LosartanSodium ChlorideDinoprostoneAngiotensin IIAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsSodium Chloride, DietaryReceptor, Angiotensin, Type 1

Authors and institutions

  • Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Toyoake, Aichi, Japan.
  • Laboratory of Health and Medical Science Innovation (HMSI), Fujita Health University Graduate School of Health Science, Toyoake, Aichi, Japan.
  • Department of Cellular Function Analysis, Research Promotion and Support Headquarters, Fujita Health University, Toyoake, Aichi, Japan.
  • Education and Research Facility of Animal Models for Human Diseases, Center for Research Promotion and Support, Fujita Health University, Toyoake, Aichi, Japan.
  • Division of Behavioral Neuropharmacology International Center for Brain Science (ICBS), Fujita Health University, Toyoake, Aichi, Japan.
  • Division of Pharmacology, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan.

ORCID profiles: Bolati Wulaer, Tomoyuki Furuyashiki, Akihiro Mouri

Funding

  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency
  • Smoking Research Foundation
  • Takeda Science Foundation

Cite

APA

Kubota, H., Kunisawa, K., Wulaer, B., Hasegawa, M., Kurahashi, H., Sakata, T., Tezuka, H., Kugita, M., Nagao, S., Nagai, T., Furuyashiki, T., Narumiya, S., Saito, K., Nabeshima, T., & Mouri, A. (2023). High salt induces cognitive impairment via the interaction of the angiotensin II‐AT 1 and prostaglandin E2‐EP 1 systems. British Journal of Pharmacology. https://doi.org/10.1111/bph.16093

Vancouver

Kubota H, Kunisawa K, Wulaer B, Hasegawa M, Kurahashi H, Sakata T, et al. High salt induces cognitive impairment via the interaction of the angiotensin II‐AT 1 and prostaglandin E2‐EP 1 systems. British Journal of Pharmacology. 2023. doi:10.1111/bph.16093

BibTeX
@article{Kubota2023,
  author = {Kubota, Hisayoshi and Kunisawa, Kazuo and Wulaer, Bolati and Hasegawa, Masaya and Kurahashi, Hitomi and Sakata, Takatoshi and Tezuka, Hiroyuki and Kugita, Masanori and Nagao, Shizuko and Nagai, Taku and Furuyashiki, Tomoyuki and Narumiya, Shuh and Saito, Kuniaki and Nabeshima, Toshitaka and Mouri, Akihiro},
  title = {High salt induces cognitive impairment via the interaction of the angiotensin II‐AT 1 and prostaglandin E2‐EP 1 systems},
  journal = {British Journal of Pharmacology},
  year = {2023},
  doi = {10.1111/bph.16093}
}
Start for free →